159 related articles for article (PubMed ID: 26131374)
21. A descriptive analysis of postmarketing requirement studies and clinical trials.
Choi L; Etchey B; Billings M; Lee C; Weil KM; Boxwell D; Edelberg H
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5725. PubMed ID: 37994284
[TBL] [Abstract][Full Text] [Related]
22. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
23. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
Ohnmeiss DD
Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
[TBL] [Abstract][Full Text] [Related]
24. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
25. Changes to registration elements and results in a cohort of Clinicaltrials.gov trials were not reflected in published articles.
Pranić S; Marušić A
J Clin Epidemiol; 2016 Feb; 70():26-37. PubMed ID: 26226103
[TBL] [Abstract][Full Text] [Related]
26. Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years.
Pellat A; Boutron I; Ravaud P
Oncologist; 2022 Nov; 27(11):e849-e855. PubMed ID: 35983949
[TBL] [Abstract][Full Text] [Related]
27. Public availability of results of trials assessing cancer drugs in the United States.
Nguyen TA; Dechartres A; Belgherbi S; Ravaud P
J Clin Oncol; 2013 Aug; 31(24):2998-3003. PubMed ID: 23878298
[TBL] [Abstract][Full Text] [Related]
28. Nonpublication Rates and Characteristics of Registered Randomized Clinical Trials in Digital Health: Cross-Sectional Analysis.
Al-Durra M; Nolan RP; Seto E; Cafazzo JA; Eysenbach G
J Med Internet Res; 2018 Dec; 20(12):e11924. PubMed ID: 30485832
[TBL] [Abstract][Full Text] [Related]
29. Reporting bias in completed epilepsy intervention trials: A cross-sectional analysis.
Rayi A; Thompson S; Gloss D; Malhotra K
Epilepsy Res; 2018 Jul; 143():1-6. PubMed ID: 29625272
[TBL] [Abstract][Full Text] [Related]
30. Impact of study outcome on submission and acceptance metrics for peer reviewed medical journals: six year retrospective review of all completed GlaxoSmithKline human drug research studies.
Evoniuk G; Mansi B; DeCastro B; Sykes J
BMJ; 2017 Apr; 357():j1726. PubMed ID: 28432051
[No Abstract] [Full Text] [Related]
31. Outcome reporting among drug trials registered in ClinicalTrials.gov.
Bourgeois FT; Murthy S; Mandl KD
Ann Intern Med; 2010 Aug; 153(3):158-66. PubMed ID: 20679560
[TBL] [Abstract][Full Text] [Related]
32. Defining the hidden evidence in autism research. Forty per cent of rigorously designed clinical trials remain unpublished - a cross-sectional analysis.
Mechler K; Hoffmann GF; Dittmann RW; Ries M
Int J Methods Psychiatr Res; 2017 Dec; 26(4):. PubMed ID: 27862603
[TBL] [Abstract][Full Text] [Related]
33. Industry Sponsor Influence in Clinical Trial Reporting in Canada: A Qualitative Interview Study.
Morrow RL; Mintzes B; Gray G; Law MR; Garrison S; Dormuth CR
Clin Ther; 2022 Mar; 44(3):374-388. PubMed ID: 34955232
[TBL] [Abstract][Full Text] [Related]
34. Creating a Program to Support Registering and Reporting Clinical Trials at Johns Hopkins University.
Keyes A; Mayo-Wilson E; Nuamah P; Lalji A; Tetteh O; Ford DE
Acad Med; 2021 Apr; 96(4):529-533. PubMed ID: 33060401
[TBL] [Abstract][Full Text] [Related]
35. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov.
Riley IL; Boulware LE; Sun JL; Chiswell K; Que LG; Kraft M; Todd JL; Palmer SM; Anderson ML
Clin Trials; 2018 Feb; 15(1):87-94. PubMed ID: 29121787
[TBL] [Abstract][Full Text] [Related]
37. Factors predicting publication of spinal cord injury trials registered on www.ClinicalTrials. gov.
DePasse JM; Park S; Eltorai AEM; Daniels AH
J Back Musculoskelet Rehabil; 2018 Feb; 31(1):45-48. PubMed ID: 28826165
[TBL] [Abstract][Full Text] [Related]
38. Phase IV Drug Trials With a Canadian Site: A Comparison of Industry and Non-Industry-Funded Trials.
Lexchin J; Dong BM; Ramanathan A; Gagnon MA
Int J Health Policy Manag; 2024 Mar; ():. PubMed ID: 38618840
[TBL] [Abstract][Full Text] [Related]
39. Compliance on Mandatory Data Reporting in Registered Obstetrics Trials.
Checketts JX; Evans MB; Athale AH; Jawhar OM; Wright MR; Bryant K; Vassar M
Am J Perinatol; 2018 Oct; 35(12):1192-1196. PubMed ID: 29695018
[TBL] [Abstract][Full Text] [Related]
40. Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices.
Miller J; Ross JS; Wilenzick M; Mello MM
BMJ; 2019 Jul; 366():l4217. PubMed ID: 31292127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
